Opaleye Management Inc. Arvinas, Inc. Transaction History
Opaleye Management Inc.
- $508 Million
- Q4 2024
A detailed history of Opaleye Management Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 1,625,000 shares of ARVN stock, worth $28.8 Million. This represents 6.13% of its overall portfolio holdings.
Number of Shares
1,625,000
Previous 1,255,000
29.48%
Holding current value
$28.8 Million
Previous $30.9 Million
0.78%
% of portfolio
6.13%
Previous 5.64%
Shares
7 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
70.9MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$125 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$119 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$111 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$72.6 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$59 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $942M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...